RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • PROF Sherene Loi
    • ESTRADA MV
    • SANCHEZ V
    • SANDERS ME
    • COOK RS
    • PILKINTON MA
    • MALLAL SA
    • WANG K
    • MILLER VA
    • STEPHENS PJ
    • YELENSKY R
    • DUSHYANTHEN S
    • DOIMI FD
    • GOMEZ H
    • RYZHOV SV
    • PROF Phillip Darcy
    • ARTEAGA CL
    • BALKO JM
    • DR Paul Beavis
    • SALGADO R
    • DENKERT C
    • SAVAS P
    • COMBS S
    • RIMM DL
    • GILTNANE JM

Published in

  • Clinical Cancer Research

Time

Date/time value

  • 2016

Identity

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-15-1125

Additional Document Info

Parent Title

  • CLINICAL CANCER RESEARCH

Volume

  • 22

Issue

  • 6

Publisher

  • American Association for Cancer Research